Next Science Limited
ASX:NXS.AX
0.12 (AUD) • At close February 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 22.179 | 16.896 | 8.641 | 3.833 | 4.11 | 2.63 | 0 | 0.086 |
| Cost of Revenue
| 5.945 | 4.991 | 2.702 | 1.365 | 9.131 | 10.371 | 0.002 | 1.302 |
| Gross Profit
| 16.235 | 11.905 | 5.939 | 2.468 | -5.021 | -7.741 | -0.002 | -1.216 |
| Gross Profit Ratio
| 0.732 | 0.705 | 0.687 | 0.644 | -1.222 | -2.944 | 0 | -14.212 |
| Reseach & Development Expenses
| 6.486 | 7.929 | 4.325 | 6.633 | 1.753 | 1.172 | 0 | 0.5 |
| General & Administrative Expenses
| 5.61 | 5.385 | 2.976 | 2.411 | 5.941 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 20.165 | 10.31 | 5.36 | 4.331 | 0.457 | 0 | 0 | 0 |
| SG&A
| 25.776 | 22.289 | 10.892 | 9.794 | 5.912 | 4.17 | 0.036 | 1.407 |
| Other Expenses
| -16.027 | 0.072 | 0.192 | 0.417 | 0.052 | 0 | 0 | 0 |
| Operating Expenses
| 16.235 | 30.218 | 15.217 | 16.427 | 7.664 | 5.342 | 0.036 | 1.907 |
| Operating Income
| -23.408 | -18.313 | -9.278 | -13.959 | -12.685 | -13.084 | -0.038 | -3.123 |
| Operating Income Ratio
| -1.055 | -1.084 | -1.074 | -3.642 | -3.087 | -4.976 | 0 | -36.494 |
| Total Other Income Expenses Net
| 7.137 | -4.704 | -1.492 | -1.147 | -1.84 | 0.117 | -0.011 | 0.679 |
| Income Before Tax
| -16.271 | -18.296 | -9.029 | -13.27 | -14.525 | -12.967 | -0.049 | -2.444 |
| Income Before Tax Ratio
| -0.734 | -1.083 | -1.045 | -3.462 | -3.534 | -4.931 | 0 | -28.562 |
| Income Tax Expense
| 0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Net Income
| -24.513 | -18.296 | -9.029 | -13.27 | -14.525 | -12.967 | -0.049 | -2.444 |
| Net Income Ratio
| -1.105 | -1.083 | -1.045 | -3.462 | -3.534 | -4.931 | 0 | -28.562 |
| EPS
| -0.1 | -0.087 | -0.046 | -0.071 | -0.084 | -0.07 | -0 | -0.014 |
| EPS Diluted
| -0.1 | -0.087 | -0.046 | -0.071 | -0.084 | -0.07 | -0 | -0.014 |
| EBITDA
| -14.422 | -17.019 | -8.515 | -13.178 | -12.113 | -12.853 | -0.036 | -2.355 |
| EBITDA Ratio
| -0.65 | -1.007 | -0.985 | -3.438 | -2.947 | -4.888 | 0 | -35.557 |